ImmuCell (ICCC) Corporation announced that it has selected Olivier te Boekhorst as its next president and CEO. The company anticipates a start date of November 1 for te Boekhorst. te Boekhorst is currently an operating partner at ARCHIMED, and serves as chair of the board of SeqCenter, a Next Generation Sequencing laboratory where he previously served as CEO.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC: